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Abstract
Background Comorbidities have major implications for the care of people with dementia.
Aim To investigate the patterns of comorbidities in dementia in the last five years of life and how these patterns differed 
between three cohorts.
Methods The study included people who died at age 70 and above in 2001 (n = 13,717), 2007 (n = 34,750) and 2013 
(n = 38,087) in Finland. ICD-10 morbidity data for a five-year period prior to death were extracted from national registers. 
Principal component analysis was employed to identify patterns for several morbidities. The associations of principal com-
ponent scores with dementia were analysed using binary logistic regression. Linear regression was used to examine changes 
in the number of morbidities in patterns over time.
Results The morbidity patterns identified in the last years of life were (1) cardiometabolic disorders, (2) neurological, (3) 
cerebrovascular diseases and (4) musculoskeletal, thyroid and psychiatric disorders. Among the patterns, neurological and 
musculoskeletal, thyroid and psychiatric disorders were associated with dementia. The number of diagnoses in the cerebro-
vascular pattern increased and those in the musculoskeletal, thyroid and psychiatric pattern decreased over time.
Discussion Comorbidity patterns identified in this nationwide register study are largely in line with previous evidence. Time 
difference in these patterns provide crucial information for service planning.
Conclusions Comorbidities in dementia in the last years of life occur in patterns and change over time. More systematic 
monitoring and updated clinical guidelines are needed for the care of comorbidities with dementia.
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Introduction
Comorbidities among people with dementia is a rising con-
cern for health care systems worldwide as the number of 
older adults continues to increase [1]. Research findings are 
contradictory: some studies report that people with dementia 
have a higher number of coexisting diseases [2, 3], some 
suggest that they are healthier [4], and some report similar 
levels of morbidity [5] as in people without dementia. The 
inconsistencies are likely to reflect the differences in studied 
populations and methods [5–8]. There is also a lack of evi-
dence on how comorbidities in dementia change over time 
[9].
Other medical conditions in dementia might accelerate 
the decline of functional and cognitive abilities [10, 11]. 
Dementia is found to complicate the management of other 
illnesses [1, 12] and conversely, treatment of comorbid con-
ditions may generate an opposite effect on the treatment 
of dementia due to improper drug combinations [4]. Fur-
thermore, especially people living with advanced dementia 
may have difficulty communicating their health problems, 
resulting in hidden comorbidities, lack of treatment and poor 
health outcomes [7]. Therefore, dementia with coexisting 
diseases requires different treatment strategies. Multidisci-
plinary coordinated care has been recommended instead of 
a single disease approach [1].
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A recent study reported that the incidence of dementia 
has declined by 13% in Europe [13] potentially explained by 
factors like improved living conditions, education, and more 
effective prevention and management of risk factors [14]. 
According to Alzheimer Europe report 2020, the prevalence 
of dementia has declined over the last decade (2008–2018), 
but the proportion of population having dementia is expected 
to double (1.57% in 2018 to 3% in 2050), because of the 
increase in ageing population, especially those above 
85 years [15]. In Finland, the number of deaths from demen-
tia has almost doubled in the last decade, and the country 
now has the highest age-adjusted dementia-related death rate 
in Europe [16]. Furthermore, as more people live in to very 
advanced age, the number of individuals with dementia is 
likely to grow [17, 18]. Increasing dementia is posing new 
requirements for care.
This study aims to identify the most common comorbidi-
ties and patterns of comorbidities in people with dementia 
in the last five years of life. Furthermore, it examines the 
differences between these patterns in 2001, 2007 and 2013. 
This information will help professionals redefine the neces-
sary clinical guidelines [9] and develop nursing care on the 
continuum of services for better health outcomes and quality 
of life.
Methods
The study population included three cohorts of people in 
Finland who died at age 70 and above in 2001 (n = 13,717), 
2007 (n = 34,750) and 2013 (n = 38,087). The first dataset 
included a random sample of 40% of the 2001 cohort and 
the two other datasets comprised all decedents aged 70 or 
over in the respective years. The data included information 
on date and age of death and gender.
ICD-10 morbidity data for a five-year period prior to 
death were extracted from national registers as described 
below. A person was considered to have the diagnosis if it 
was indicated in any of the three source registers, namely 
The Causes of Death Register (Statistics Finland), The Care 
Register for Health Care and The Care Register for Social 
Welfare (Finnish Institute for Health and Welfare). These 
exhaustive registers cover every individual living in Finland 
and their use of health care, and the principle of registers 
have remained the same across study cohorts. Informa-
tion on direct, immediate and underlying causes and other 
morbidities leading to death were extracted from the death 
register. The dementia group was identified using ICD-10 
codes F00 (dementia in Alzheimer’s disease), F01 (vascular 
dementia), F02 (dementia in other diseases), F03 (unspeci-
fied dementia) or G30 (Alzheimer’s disease). In addition 
to dementia, the other diagnoses included in our analyses 
were hypertension (I10–I16), coronary artery disease (CAD) 
(I20–I25), diabetes (E10–E14), stroke (I60–I69), Parkinson’s 
disease or other neurological diseases (G00–G99 excluding 
G30), atherosclerosis or peripheral arterial occlusive dis-
ease (I65, I66, I67.2, I70, I73.9), cardiac insufficiency (I50), 
asthma or chronic obstructive pulmonary disease (COPD) 
(J40–J47), cancer (C00–C97), hip fracture (S72), thyroid 
disorders (E01–E07), diseases of lipoprotein metabolism 
and other lipidemias (E78), psychotic or neurotic disorders 
(F20–F29, F40–F48), depression (F32, F33), insomnia (F51, 
G47), joint arthrosis (M15–M19), osteoporosis (M80–M82) 
and renal insufficiency or failure (N17–N19). The list of 
morbidities was based on conditions found to be the most 
prevalent in the older population [7] and conditions associ-
ated with dementia in the previous literature [2, 12].
This study is part of the ongoing project: the longevity 
revolution: implications for the need and cost of health and 
social care (COCTEL) [19].
Statistical analysis
The study participants’ characteristics were described as 
frequencies and percentages or means and standard devia-
tions (SD). To determine the impact of dementia and time, 
differences between people with and without dementia and 
between the three cohorts were tested by independent sam-
ples t test for continuous variables and by Pearson’s Chi-
squared test for categorical variables. A Mantel–Haenszel 
test was performed to investigate the trend in the proportion 
of people with and without dementia across the cohorts. We 
calculated the proportions of morbidities in the three cohorts 
of people with dementia, and then estimated odds ratios for 
each morbidity with cohort as the independent variable from 
binary logistic regression. Finally, we tested the linear trend 
of odds ratios for morbidities using the contrast command 
in Stata.
Principal component analysis (PCA) was used to identify 
morbidity patterns. PCA is a dimensionality reduction tech-
nique that was used to reduce the large number of diseases 
into a smaller number of components while retaining most 
of the relevant information in the large dataset. The number 
of components extracted depended on the eigenvalue (vari-
ances of the principal components) ≥ 1, scree plot (graphical 
plot of eigenvalues against component numbers) and clini-
cally meaningful interpretable components. We proceeded 
with PCA as Bartlett’s test showed a significance of < 0.001. 
Component loadings > 0.3 were considered significant 
[20–23]. Chronic respiratory diseases had loadings > 0.3 in 
two components and negative loading in one component, and 
cancer was negatively loaded on two components and hence 
were excluded from PCA. Next, the associations of the prin-
cipal component scores with dementia were examined by 
binary logistic regression analysis adjusted for age at death 
and gender. Finally, a linear regression model (adjusted for 
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age at death and gender) with an interaction term between 
dementia and cohort was used to examine changes in the 
number of diseases in the morbidity patterns over time. As 
the number of diseases may have been affected by increas-
ing age at death across the cohorts, we also run the analyses 
without age adjustment. Statistical analyses were performed 
using Stata 15 (College Station, TX, USA) and SPSS 25 
(Armonk, NY, USA). We considered statistical significance 
at p < 0.05.
Results
Almost one-third (31.7%) of the study population 
(n = 86,554) had dementia at the time of death. The figures 
for 2001, 2007 and 2013 were 24.5%, 30.2% and 35.6%, 
respectively. In each cohort, the share of women and mean 
age at death were significantly higher in people with demen-
tia than in people without dementia. In people with demen-
tia, the age and gender standardised mean number of mor-
bidities increased significantly between the first two cohorts 
and then decreased slightly in the most recent cohort, still 
remaining at a higher level than in the first cohort (3.52, 3.77 
and 3.74), while in people without dementia that number 
increased steadily (2.84, 3.08 and 3.20) (Table 1).
Table 2 reports the comorbidities for people with demen-
tia over time. In the most recent year, the most prevalent 
comorbidities were coronary artery disease (37.3%), hyper-
tension (36.0%), cardiac insufficiency (24.3%), and stroke 
(22.5%). Stroke, hip fracture, atherosclerosis, psychotic or 
neurotic disorders and depression decreased significantly 
across time while hypertension, cardiac insufficiency, dia-
betes, cancer, lipoprotein disorders, renal insufficiency, 
osteoporosis, insomnia and thyroid disorders increased. No 
significant cohort differences were found for coronary artery 
disease, Parkinson’s disease, or joint arthrosis.
PCA revealed four morbidity patterns in the whole sam-
ple (Table 3). The first component, cardiometabolic disor-
ders, had heavy loadings (factor loading > 0.4) on cardiac 
insufficiency, coronary artery disease, renal insufficiency, 
diabetes and atherosclerosis or peripheral arterial occlusive 
disease. The second component was named as neurological 
diseases, with heavy loadings on insomnia and Parkinson’s 
disease or other neurological diseases. The third compo-
nent was cerebrovascular diseases due to heavy loadings 
on hypertension, diseases of lipoprotein metabolism and 
Table 1  Characteristics [percentage or mean with standard deviation (SD)] of the study population (n = 86,554): people above 70 years who died 
in 2001, 2007 and 2013
*Dementia included
1 Pearson’s Chi-squared test (people with and without dementia within year)
2 Independent samples t test (people with and without dementia within year)
3a Mantel–Haenszel test for trend (within group)
3b From linear regression model (within group)
Characteristics People with dementia People without dementia
2001 2007 2013 p value 2001 2007 2013 p value
n (%) 3358 (24.5) 10,479 (30.2) 13,577 (35.6)  < 0.0013a 10,359 (75.5) 24,271 (69.8) 24,510 (64.4)
Women (%) 69.0 66.4 65.4  < 0.0013a 55.5 53.2 51.6  < 0.0013a
Age at death (%)
 70–79 21.2 16.3 13.2 40.6 37.1 35.0
 80–89 50.7 52.7 51.0 42.9 44.5 44.4
 ≥ 90 28.1 31.0 35.8 16.5 18.4 20.6
 p  value1  < 0.001  < 0.001  < 0.001
Age at death, mean (SD) 85.3 (6.4) 86.0 (6.4) 86.9 (6.3) 81.9 (7.0) 82.5 (7.2) 82.9 (7.4)
 p  value2  < 0.001  < 0.001  < 0.001
Mean number of diagnoses*
 Crude 3.53 3.77 3.74  < 0.0013b 2.82 3.08 3.21  < 0.0013b
 Adjusted for age and gender 3.52 3.77 3.74  < 0.0013b 2.84 3.08 3.20  < 0.0013b
Level of comorbidity
 0 6.3 5.9 7.4 2.3 2.2 2.4
 1–2 46.9 41.3 40.5 44.2 38.1 35.2
 3–4 36.3 37.9 36.9 39.4 40.3 40.4
 ≥ 5 10.5 14.9 15.2 14.1 19.4 22.1
 p  value1  < 0.001  < 0.001  < 0.001
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Table 2  Proportions of people 
having different comorbidities 
with dementia in 2001, 2007 
and 2013, differences between 
the years (odds ratios from 
binary regression models) and p 
values for time trend




Comorbidity Proportions Odds ratios (ref = 2001) p for-trend of 
odds ratios
2001 2007 2013 2007 2013
CAD 38.8 44.2 37.3 1.25*** 0.94 0.13
Hypertension 18.6 28.3 36.0 1.73*** 2.47***  < 0.001
Cardiac insufficiency 21.0 24.9 24.3 1.25*** 1.21***  < 0.001
Stroke 25.4 24.5 22.5 0.95 0.85***  < 0.001
Parkinson’s disease/neuro-
logical diseases
18.1 18.5 18.1 1.03 1.00 0.99
Diabetes 14.6 16.9 16.2 1.19** 1.14* 0.019
Hip fracture 16.6 15.7 14.0 0.93 0.81***  < 0.001
Cancer 11.6 13.5 14.4 1.19** 1.28***  < 0.001
Atherosclerosis 9.2 7.9 6.5 0.85* 0.69***  < 0.001
Asthma /COPD 7.4 9.0 9.1 1.22** 1.25** 0.001
Psychosis/ neurosis 4.3 3.3 2.6 0.77** 0.58***  < 0.001
Depression 5.7 4.0 2.8 0.69*** 0.48***  < 0.001
Joint arthrosis 5.7 6.3 5.8 1.11 1.03 0.71
Thyroid disorders 2.7 3.0 3.4 1.12 1.28* 0.037
Renal insufficiency 2.2 4.1 7.1 1.89*** 3.41***  < 0.001
Osteoporosis 2.0 4.0 4.5 2.02*** 2.28***  < 0.001
Insomnia 0.5 0.8 1.3 1.55** 2.47***  < 0.001
Lipoprotein disorders 0.2 1.2 3.1 5.3*** 13.2***  < 0.001
Table 3  Principal component loading matrix for morbidities representing the four morbidity patterns identified through principal component 
analysis
Bold indicates factor loadings of morbidities in the pattern













Cardiac insufficiency 0.78 0.03 − 0.04 0.10
CAD 0.63 − 0.01 0.08 − 0.07
Renal insufficiency 0.60 − 0.04 0.08 − 0.02
Diabetes 0.49 0.19 0.36 − 0.14
Atherosclerosis 0.35 0.05 0.22 − 0.18
Insomnia 0.17 0.89 − 0.01 − 0.06
Parkinson’s disease/neurological diseases − 0.14 0.83 0.14 0.06
Hypertension 0.30 0.10 0.65 0.19
Lipoprotein disorders 0.00 0.13 0.64 0.02
Stroke − 0.14 0.23 0.59 − 0.07
Osteoporosis 0.06 − 0.15 0.02 0.60
Depression − 0.04 0.26 0.04 0.59
Hip fracture 0.01 − 0.12 − 0.00 0.49
Thyroid disorders 0.02 − 0.04 0.20 0.45
Psychosis / neurotic disorders − 0.10 0.22 − 0.16 0.44
Joint arthrosis 0.11 − 0.04 0.16 0.34
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stroke. The last component, musculoskeletal, thyroid and 
psychiatric disorders, included osteoporosis, hip fracture, 
joint arthrosis, thyroid disorders, depression and psychotic 
or neurotic disorders.
Table 4 demonstrates the association between the princi-
pal component scores of the patterns identified and dementia 
(adjusted for age, gender and cohort). The odds of having 
dementia was higher for those whose principal scores for 
neurological diseases  (ORadj 1.79, 95% confidence interval 
(CI) 1.65–1.93) and musculoskeletal, thyroid and psychiat-
ric disorders  (ORadj 1.78, 95% CI 1.64–1.92) were higher. 
Meanwhile, the odds of having dementia was lower for those 
whose principal scores for cardiometabolic disorders  (ORadj 
0.34, 95% CI 0.32–0.35) and cerebrovascular diseases  (ORadj 
0.71, 95% CI 0.67–0.74) were higher.
Figure 1 shows the observed means in the three cohorts 
and fitted trajectories for changes in the number of diseases 
in the morbidity patterns over time in people with demen-
tia from the linear regression model. There was a signifi-
cant increase in cerebrovascular diseases (p < 0.001) and a 
decrease in musculoskeletal, thyroid and psychiatric disor-
ders (p < 0.001). The decreases in cardiometabolic disor-
ders (p = 0.11) and neurological and lung-related diseases 
(p = 0.32) were not statistically significant. Cardiometabolic 
disorders was the only disease pattern that showed a different 
time trend depending on whether the changing age structure 
was taken into account. Without age adjustment, there was a 
slight increase in cardiometabolic diagnoses but that turned 
to decline when adjusted for age.
Discussion
We found mixed time trends for comorbidities in the last 
years of life of people with dementia: some increased, a 
few decreased and some were stable between the cohorts. 
The most frequent conditions in people with dementia were 
coronary artery disease followed by hypertension, cardiac 
insufficiency and stroke. Our findings are supported by pre-
vious research which has reported that hypertension [1, 2], 
cardiovascular diseases, stroke and diabetes are the most 
common diseases among people with dementia [12].
Changes in comorbid conditions over time
Trends in the chronic disease burden in the older population 
have been quite extensively explored [24, 25], but to our 
knowledge, there are no previous studies on how comor-
bidities in people with dementia change over time. Of the 
Table 4  Associations of principal component scores of morbidity pat-
terns with dementia. Odds ratios, 95% confidence intervals and p val-
ues from logistic regression model
*Principal component score




Cardiometabolic disorders* 0.34 0.32–0.35  < 0.001
Neurological disorders* 1.79 1.65–1.93  < 0.001
Cerebrovascular diseases* 0.71 0.67–0.74  < 0.001
Musculoskeletal, thyroid and 
psychiatric disorders*
1.78 1.64–1.92  < 0.001
Age at death 1.08 1.08–1.08  < 0.001
Gender (ref. male) 1.33 1.28–1.37  < 0.001
Cohort (ref. 2001)
 2007 1.35 1.29–1.42  < 0.001
 2013 1.66 1.59–1.75  < 0.001
Fig. 1  Mean number of diseases 
in the four morbidity patterns in 
the three cohorts. Trajectories 
from linear regression models, 
adjusted for gender (solid line) 
and additionally adjusted for 
age at death (dotted line)
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diagnoses, hypertension, cancer, renal insufficiency, osteo-
porosis, insomnia and lipoprotein disorders became more 
frequent in people with dementia. The increasing prevalence 
of hypertension may be due to lowered blood pressure cut-
offs for diagnosis [26]. Diabetes has increased over time, 
which may explain the increasing occurrence of renal insuf-
ficiency in the sample. Among cardiovascular diseases, car-
diac insufficiency increased while coronary artery diseases 
showed no change in people with dementia. An earlier Finn-
ish study reported a decrease in cardiovascular diseases in 
working-age people due to a reduction in risk factors and a 
shift to older age due to better treatment and survival [27]. 
An increasing trend in the prevalence of comorbidities may 
partly be due to increasing life expectancy, changing diag-
nostic criteria, more active diagnosing of dementia and some 
of the comorbidities, and the availability of more effective 
drugs [25]. The prevalence of comorbidities varies with the 
type of dementia and increases with severity of cognitive 
impairment [2, 8].
Comorbidity patterns and their associations 
with dementia
A better understanding of conditions that coexist with 
dementia in specific patterns is crucial for care planning 
[11]. Using PCA, a novel way to summarise complex con-
ditions, we were able to identify four morbidity patterns, two 
of which were associated with dementia. The coexistence of 
neurological pattern with dementia represents a clinically 
interpretable pattern and is supported by previous studies 
[28–30]. Insomnia is found to be associated with increased 
risk of dementia and is one of the most common symptoms 
in Parkinson’s disease [29], thus explaining the pattern.
Despite differences in methodological and statistical 
approaches, earlier studies have consistently identified 
cardiometabolic, mental health, musculoskeletal, and neu-
ropsychiatric patterns in adults [6, 23]. Such patterns might 
stem from similar risk factors or common pathophysiologi-
cal mechanisms [9]. The diseases in the fourth pattern we 
identified—musculoskeletal, thyroid and psychiatric dis-
orders—are interrelated: it has been reported that people 
on medications for depression or psychosis, with adverse 
effects such as sedation and hypotension, are at greater risk 
for falls and fractures [31]. There are several reports of a 
significant association between depression and osteoporo-
sis [32] and hypothyroidism and depression [33], lending 
support to the convergence thesis. The evidence suggests 
associations between dementia and depression [7], hip frac-
ture [31], higher thyroid function [34] and osteoporosis [35]. 
These associations underline the need for early diagnosis 
and management of depression and osteoporosis as well 
as the importance of identifying the type of thyroid disor-
ders associated with dementia. Our results are in line with 
existing reports on disease patterns coexisting with demen-
tia in older adults, including anxiety, depression, somato-
form disorders and pain, and neuropsychiatric disorders [2, 
28]. The morbidity pattern showing the greatest increase 
over time was that of cerebrovascular diseases, a group not 
specifically associated with dementia. Among the patterns 
that were more frequent in dementia patients than in those 
without dementia, musculoskeletal, thyroid and psychiatric 
disorders showed a significant decline between the cohorts. 
The decrease in this pattern is attributable to the decrease 
in several diagnoses associated with this pattern, namely 
hip fracture, psychotic or neurotic disorders and depression, 
while osteoporosis and thyroid disorders increased.
This first nationwide study in Finland provides informa-
tion on changes over time in comorbidity in dementia and 
introduces a novel approach to comorbidity research by 
employing PCA to detect concurrent diagnoses in demen-
tia. It overcomes many limitations of earlier comorbidity 
studies, drawing its data from multiple national registers 
and using a comprehensive list of morbidities and disease 
patterns instead of any single disease [9]. The exhaustive 
registers contain information on every individual in Finland. 
Diagnosis of dementia (ICD10) is entered in the Care Reg-
ister for Health Care or the Care Register for Social Wel-
fare when a person with dementia is admitted to care, i.e., 
uses the service. In addition, the Causes of Death Register 
includes information on dementia diagnosis. These practices 
have not changed from 2001 to 2013, and we have no reason 
to suspect differences between the study years in this respect. 
It is important to note, however, that we can draw no infer-
ences about causality between dementia and comorbidities 
and that the trends observed must be interpreted with caution 
as they largely depend on the population, clinical criteria 
used, hospital reporting, death registry data and health seek-
ing patterns [5, 7]. People in the advanced stages of demen-
tia may not be able to communicate their symptoms, which 
may lead to underestimation of several medical conditions. 
Furthermore, there may be differences in the associations of 
different subtypes of dementia, but our main concern here 
is with population health needs and care organisation rather 
than etiology. As the age structure and chronic conditions 
among old are approximately similar, we believe that largely 
our findings are applicable to Europe, especially Northern 
countries [36].
Our findings warrant the development of improved mod-
els of dementia care, both clinical and social, that antici-
pate the future scale of dementia and its comorbidities. New 
clinical guidelines are needed for coexisting diseases as most 
current guidelines are disease-specific [22], often leading to 
polypharmacy, drug interactions and iatrogenic events [3]. 
Coordination and communication between specialists and 
primary care providers may help to attain the best possible 
outcomes.
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In conclusion, our study highlights the medical complex-
ity associated with dementia, underscoring the importance 
of regular monitoring and an integrated treatment protocol 
with a multiple disease approach. This will help to improve 
the quality of life of people with dementia. Further research 
should focus on the mechanisms in the relationship between 
comorbidity patterns and dementia and its subtypes.
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